P00746 (CFAD_HUMAN) Homo sapiens (Human)
Complement factor D UniProtKBInterProSTRINGInteractive Modelling
253 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
40 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Inhibiting Alternative Pathway Complement Activation by Targeting the Exosite on Factor D |
Heteromer P01834; P01857; | |||||
| Assess | ||||||
| Crystal structure of human Complement Factor D with anti-Factor D Fab 20D12 |
Heteromer | 1×CIT; | ||||
| Assess | ||||||
| Crystal structure of human Complement Factor D with anti-Factor D Fab 20D12 |
Heteromer | 1×GOL; 1×SO4; | ||||
| Assess | ||||||
| Crystal Structure of Complement C3b in complex with Factors B and D |
Heteromer P00751; P01024; | 2×NAG; 1×NAG; 2×MG; 2×NAG; 1×GOL; | ||||
| Assess | ||||||
| HUMAN FACTOR D, COMPLEMENT ACTIVATING ENZYME | homo-2-mer | |||||
| Assess | ||||||
| FACTOR D INHIBITED BY DIISOPROPYL FLUOROPHOSPHATE | homo-2-mer | 2×DFP; | ||||
| Assess | ||||||
| Complement factor D in complex with the inhibitor (S)-Pyrrolidine-1,2-dicarboxylic acid 1-[(1-methy… | monomer | 2×GOL; 1×8RT; | ||||
| Assess | ||||||
| Crystal Structure of Complement Factor D mutant S183A | monomer | 4×GOL; | ||||
| Assess | ||||||
| Complement factor D in complex with the inhibitor (1R,3S,5R)-2-Aza-bicyclo[3.1.0]hexane-2,3-dicarbo… | monomer | 1×8RZ; | ||||
| Assess | ||||||
| COMPLEMENT FACTOR D IN COMPLEX WITH A REVERSIBLE INDOLE CARBOXYLIC ACID BASED INHIBITOR | monomer | 1×QJS; 1×SO4; | ||||
| Assess | ||||||
| Complement factor D | monomer | 2×DMS; 1×8NQ; | ||||
| Assess | ||||||
| Complement factor D in complex with the inhibitor (4-((3-(aminomethyl)phenyl)amino)quinazolin-2-yl)… | monomer | 1×E88; | ||||
| Assess | ||||||
| COMPLEMENT FACTOR D IN COMPLEX WITH COMPOUND2 | monomer | 1×GOL; 1×5W5; | ||||
| Assess | ||||||
| COMPLEMENT FACTOR D IN COMPLEX WITH COMPOUND 3b | monomer | 1×GOL; 1×5WD; | ||||
| Assess | ||||||
| Complement factor D in complex with the inhibitor (S)-3'-(aminomethyl)-N-(1,2,3,4-tetrahydronaphtha… | monomer | 1×E82; 1×SIN; | ||||
| Assess | ||||||
| HUMAN COMPLEMENT FACTOR D IN COMPLEX WITH ISATOIC ANHYDRIDE INHIBITOR | monomer | 1×SOA; 1×GOL; | ||||
| Assess | ||||||
| Complement factor D in complex with the inhibitor (S)-pyrrolidine-1,2-dicarboxylic acid 1-[(1-carba… | monomer | 1×SO4; 1×8RW; | ||||
| Assess | ||||||
| COMPLEMENT FACTOR D IN COMPLEX WITH A REVERSIBLE BENZOIC ACID BASED INHIBITOR | monomer | 1×M7O; | ||||
| Assess | ||||||
| COMPLEMENT FACTOR D COMPLEXED WITH COMPOUND 6 | monomer | 1×E7E; | ||||
| Assess | ||||||
| COMPLEMENT FACTOR D COMPLEXED WITH COMPOUND 5 | monomer | 1×E7H; 1×GOL; | ||||
| Assess | ||||||
| Complement factor D in complex with the inhibitor (2S,4S)-4-Amino-pyrrolidine-1,2-dicarboxylic acid… | monomer | 1×8S2; | ||||
| Assess | ||||||
| Complement factor D in complex with the inhibitor 2-(2-(3'-(aminomethyl)-[1,1'-biphenyl]-3-carboxam… | monomer | 1×J7B; | ||||
| Assess | ||||||
| STRUCTURE OF 3,4-DICHLOROISOCOUMARIN-INHIBITED FACTOR D | monomer | 1×DIC; 2×O; | ||||
| Assess | ||||||
| Crystal structure of Complement Factor D mutant R202A after conventional refinement | monomer | 1×GOL; | ||||
| Assess | ||||||
| Crystal structure of Complement Factor D mutant R202A after ensemble refinement | monomer | 1×GOL; | ||||
| Assess | ||||||
| COMPLEMENT FACTOR D IN COMPLEX WITH COMPOUND 5 | monomer | 1×5WC; 1×SO4; | ||||
| Assess | ||||||
| Complement factor D in complex with the inhibitor (2S,4R)-4-Fluoro-pyrrolidine-1,2-dicarboxylic aci… | monomer | 1×8S5; | ||||
| Assess | ||||||
| Scaffold Hopping via Ring Opening Enables Identification of Acyclic Compounds as New Complement Fac… | monomer | 1×S7X; | ||||
| Assess | ||||||
| Complement factor D in complex with the inhibitor (S)-2-(2-((3'-(1-amino-2-hydroxyethyl)-[1,1'-biph… | monomer | 1×J6T; | ||||
| Assess | ||||||
| MUTANT OF FACTOR D WITH ENHANCED CATALYTIC ACTIVITY | monomer | |||||
| Assess | ||||||
| PROENZYME OF HUMAN COMPLEMENT FACTOR D, RECOMBINANT PROFACTOR D | monomer | |||||
| Assess | ||||||
| Scaffold Hopping via Ring Opening Enables Identification of Acyclic Compounds as New Complement Fac… | monomer | 1×QIE; | ||||
| Assess | ||||||
| Complement factor D in complex with the inhibitor 3-((3-((3-(aminomethyl)phenyl)amino)-1H-pyrazolo[… | monomer | 1×E85; | ||||
| Assess | ||||||
| Scaffold Hopping via Ring Opening Enables Identification of Acyclic Compounds as New Complement Fac… | monomer | 1×R7X; | ||||
| Assess | ||||||
| Complement factor D in complex with the inhibitor N-(3'-(aminomethyl)-[1,1'-biphenyl]-3-yl)-3-methy… | monomer | 1×E8B; | ||||
| Assess | ||||||
| HUMAN COMPLEMENT FACTOR D IN A P21 CRYSTAL FORM | monomer | |||||
| Assess | ||||||
| Crystal Structure of Complement Factor D Mutant R202A | monomer | 1×GOL; | ||||
| Assess | ||||||
| Complement Factor D inhibited with JH3 | monomer | 1×J55; | ||||
| Assess | ||||||
| Complement Factor D inhibited with JH4 | monomer | 1×J56; | ||||
| Assess | ||||||
| Complement factor D in complex with the inhibitor 3-((3-((3-(aminomethyl)phenyl)amino)-1H-pyrazolo[… | monomer | 1×E7W; | ||||
| Assess | ||||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 6qmr.1.A | monomer | 0.88 | 1×J6T; | 100.00 | ||
| Assess | ||||||